1.79000 EUR
0.01
0.56%
Last update Dec 12, 3:29 PM CET
Main market
Day range
1.79000
1.80000
Previous close
1.78000
Open
1.80000
Access this stock data via API
Subscribe
NRX Pharmaceuticals Inc.
1.79
0.01
0.56%

Statistics

Valuation metrics
Market cap
50.29M
Enterprise value
45.46M
Trailing P/E (ttm)
-0.76
Forward P/E
PEG ratio
-0.01
Price/Sales (ttm)
207.83
Price/Book (mrq)
-1.55
Enterprise Value/Revenue
220.52
Enterprise Value/EBITDA
-3.51
Overview
Shares outstanding
27.68M
Float
20.33M
Shares short
% Held by insiders
9.77%
% Held by institutions
25.06%
Average volume (10 days)
550
Average volume (90 days)
596
Price summary
52-Week low
1.45
52-Week high
4.86
52-Week change
-171.51 -11,828.1%
Beta
1.92
50-Day moving average
2.30
200-Day moving average
2.26
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
0
Operating margin
-1,701.65%
Operational effectiveness
Return on assets
-97.83%
Return on equity
108.19%
Income statement
Revenue (ttm)
206.13K
Revenue per share (ttm)
0.01
Quarterly revenue growth (yoy)
Gross profit (ttm)
123.51K
EBITDA
-12.95M
Net income to common (ttm)
-32.42M
Diluted EPS (ttm)
-1.97
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
6.12M
Total cash per share (mrq)
0.26
Total debt (mrq)
8.74M
Total Debt/Equity (mrq)
-0.40
Current ratio (mrq)
29.40%
Book value per share (mrq)
-0.79
Cash flow
Cash flow statement
-10.64M
Levered free cash flow (LFCF)
2.54M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 13 hours 27 minutes

08:32
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).